Health Canada - Federal department responsible for drug approvals and health regulation in Canada
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| TARO-RIVAROXABAN | Taro Pharmaceuticals Inc | Marketed | Nov 1, 2023 | Marketed |
| TARO-RIVAROXABAN | Taro Pharmaceuticals Inc | Marketed | Nov 1, 2023 | Marketed |
| APO-RIVAROXABAN | Apotex Inc | Marketed | Nov 1, 2023 | Marketed |
| SANDOZ RIVAROXABAN | Sandoz Canada, Inc. | Marketed | Nov 1, 2023 | Marketed |
| REDDY-RIVAROXABAN | dr reddy's laboratories ltd | Marketed | Nov 1, 2023 | Marketed |
| SANDOZ RIVAROXABAN | Sandoz Canada, Inc. | Marketed | Nov 1, 2023 | Marketed |
| HAWAIIAN TROPIC SUNSCREEN OIL SPRAY | edgewell personal care canada, ulc | Marketed | Nov 1, 2023 | Marketed |
| PMS-RIVAROXABAN | Pharmascience Inc | Marketed | Nov 1, 2023 | Marketed |
| REDDY-RIVAROXABAN | dr reddy's laboratories ltd | Marketed | Nov 1, 2023 | Marketed |
| SANDOZ RIVAROXABAN | Sandoz Canada, Inc. | Marketed | Nov 1, 2023 | Marketed |
| APO-RIVAROXABAN | Apotex Inc | Marketed | Nov 1, 2023 | Marketed |
| REDDY-RIVAROXABAN | dr reddy's laboratories ltd | Marketed | Nov 1, 2023 | Marketed |
| APO-RIVAROXABAN | Apotex Inc | Marketed | Nov 1, 2023 | Marketed |
| ERLEADA | Janssen Inc | Marketed | Nov 1, 2023 | Marketed |
| APO-AZELASTINE/FLUTICASONE | Apotex Inc | Marketed | Oct 31, 2023 | Marketed |
| MINT-BETAHISTINE | mint pharmaceuticals inc | Marketed | Oct 31, 2023 | Marketed |
| ANTICOAGULANT SODIUM CITRATE SOLUTION, USP | fresenius kabi canada ltd | Marketed | Oct 31, 2023 | Marketed |
| AURO-LURASIDONE | auro pharma inc | Marketed | Oct 30, 2023 | Marketed |
| PMS-METHYLPHENIDATE CR | Pharmascience Inc | Marketed | Oct 30, 2023 | Marketed |
| AURO-LURASIDONE | auro pharma inc | Marketed | Oct 30, 2023 | Marketed |
